Peptides binding to bone marrow stromal cell antigen

Details Peptides binding to bone marrow stromal cell antigen Peptides binding to bone marrow stromal cell antigen

C - Chemistry, Metallurgy

07

K

C07K 7/08 (2006.01) A61K 38/10 (2006.01) A61K 39/385 (2006.01) A61K 47/48 (2006.01) C07K 1/107 (2006.01) C07K 1/22 (2006.01) C07K 17/02 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2269103

The present invention is directed to peptides capable of binding to bone marrow stromal cell antigen-1 (BST-1), and peptides capable of binding to BST-1 and inhibiting ADP-ribosyl cyclase activity and cADP-ribose hydrolase activity thereof. The peptides are useful for treating rheumatoid arthritis and multiple myeloma.

Affiliated with

Also associated with

Rating

Peptides binding to bone marrow stromal cell antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides binding to bone marrow stromal cell antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides binding to bone marrow stromal cell antigen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1962808